Home > Insider Trading > Filing (0001214659-24-012571)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1527728	Renovaro Inc.	RENB	Pharmaceutical Preparations (2834)	452259340

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1753085	Wittekind Anderson William	8581 Santa Monica Blvd. #317 West Hollywood CA 90069		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2024-07-15	21,954	$1.41	875,795	No	4	S	Indirect	Weird Science LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	Weird Science LLC

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	3,703,878	Direct
Common Stock	1,500,568	Indirect	GRATs
Common Stock	12,438,431	Indirect	Spouse

Footnotes

The price reported in column 4 is a weighted average price. These shares were sold at prices ranging from $1.40 to $1.44, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the reported range.
The Reporting Person is sole manager of Weird Science LLC.
Includes 88,121 shares held by the Reporting Person and his spouse as joint tenants with a right of survivorship (JTWROS).
Shares held by certain grantor retained annuity trusts (GRATs) of which the Reporting Person is the sole trustee.
Excludes 88,121 shares held with the Reporting Person as JTWROS. Such shares are included in the Reporting Person's direct beneficial ownership as described in note 3 above. A writ of attachment issued on July 7, 2022 by the United States District Court for the District of Vermont in The Estate of Gregory Davis et. al. v. Serhat Daniel Gumrukcu (Civil Case No. 5:22-cv-123) includes these 12,438,431 shares.
The Reporting Person disclaims beneficial ownership of these shares for purposes of Section 16, except to the extent of his pecuniary interest therein.